One test, four diseases: new device aims to simplify screening in africa
NCT ID NCT07170748
Summary
This study is evaluating a new point-of-care medical device called MagIA H3S. The device is designed to screen for four major infections—HIV, hepatitis B, hepatitis C, and syphilis—from a single blood sample. Researchers in Ivory Coast and Kenya will test its accuracy compared to standard lab tests using samples from about 3,000 people. The goal is to see if this faster, combined test can reliably detect these infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre de Diagnostic et de Recherche sur le SIDA et les autres Maladies Infectieuses - CHU Treichville
RECRUITINGAbidjan, Côte d’Ivoire
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Kenya Medical Research Institute (KEMRI)
RECRUITINGNairobi, Kenya
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.